Safety and practicality study of using an exoskeleton in acute neurosurgery patients.

Acute neuro care Brain hemorrhage Early mobilization Gait-balanced exoskeleton Neurosurgery Patient-centered rehabilitation. Pulmonary embolism Robot-assisted rehabilitation Stroke Traumatic brain injury

Journal

Acta neurochirurgica
ISSN: 0942-0940
Titre abrégé: Acta Neurochir (Wien)
Pays: Austria
ID NLM: 0151000

Informations de publication

Date de publication:
20 May 2024
Historique:
received: 23 01 2024
accepted: 01 05 2024
medline: 20 5 2024
pubmed: 20 5 2024
entrez: 19 5 2024
Statut: epublish

Résumé

Early mobilization is key in neurologically impaired persons, limiting complications and improving long-term recovery. Self-balanced exoskeletons are used in rehabilitation departments to help patients stand and walk. We report the first case series of exoskeleton use in acute neurosurgery and intensive care patients, evaluating safety, clinical feasibility and patients' satisfaction. We report a retrospective observational study including individuals hospitalized in the neurosurgical intensive care and neurosurgery departments. We included patients with a medical prescription for an exoskeleton session, and who met no contraindication. Patients benefited from standing sessions using a self-balanced exoskeleton (Atalante, Wandercraft, France). Patients and sessions data were collected. Safety, feasibility and adherence were evaluated. Seventeen patients were scheduled for 70 standing sessions, of which 27 (39%) were completed. They were typically hospitalized for intracranial hemorrhage (74%) and presented with unilateral motor impairments, able to stand but with very insufficient weight shifting to the hemiplegic limb, requiring support (MRC 36.2 ± 3.70, SPB 2.0 ± 1.3, SPD 0.7 ± 0.5). The average duration of standing sessions was 16 ± 9 min. The only side effect was orthostatic hypotension (18.5%), which resolved with returning to seating position. The most frequent reason for not completing a session was understaffing (75%). All patients were satisfied and expressed a desire to repeat it. Physiotherapy using the exoskeleton is safe and feasible in the acute neurosurgery setting, although it requires adaptation from the staff to organize the sessions. An efficacy study is ongoing to evaluate the benefits for the patients.

Identifiants

pubmed: 38763932
doi: 10.1007/s00701-024-06112-z
pii: 10.1007/s00701-024-06112-z
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

221

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.

Références

Apra C, Serra M, Robert H, Carpentier A (2022) Early rehabilitation using gait exoskeletons is possible in the neurosurgical setting, even in patients with cognitive impairment. Neurochirurgie 68(4):458–460
doi: 10.1016/j.neuchi.2021.12.010 pubmed: 35260273
Bowen DJ, Kreuter M, Spring B et al (2009) How we design feasibility studies. Am J Prev Med 36(5):452–457
doi: 10.1016/j.amepre.2009.02.002 pubmed: 19362699 pmcid: 2859314
Cuschieri S (2019) The STROBE guidelines. Saudi J Anaesth 13(Suppl 1):S31–S34
doi: 10.4103/sja.SJA_543_18 pubmed: 30930717 pmcid: 6398292
Langhorne P, Wu O, Rodgers H, Ashburn A, Bernhardt J (2017) A Very Early rehabilitation trial after stroke (AVERT): a phase III, multicentre, randomised controlled trial. Health Technol Assess 21(54):1–120
doi: 10.3310/hta21540 pubmed: 28967376 pmcid: 5641820
Lee SY, Amatya B, Judson R, Truesdale M, Reinhardt JD, Uddin T, Xiong X-H, Khan F (2019) Clinical practice guidelines for rehabilitation in traumatic brain injury: a critical appraisal. Brain Inj 33(10):1263–1271
doi: 10.1080/02699052.2019.1641747 pubmed: 31314607
Lo K, Stephenson M, Lockwood C (2017) Effectiveness of robotic assisted rehabilitation for mobility and functional ability in adult stroke patients: a systematic review. JBI Database System Rev Implement Rep 15(12):3049–3091
doi: 10.11124/JBISRIR-2017-003456 pubmed: 29219877
Louie DR, Mortenson WB, Durocher M, Teasell R, Yao J, Eng JJ (2020) Exoskeleton for post-stroke recovery of ambulation (ExStRA): study protocol for a mixed-methods study investigating the efficacy and acceptance of an exoskeleton-based physical therapy program during stroke inpatient rehabilitation. BMC Neurol 20(1):35
doi: 10.1186/s12883-020-1617-7 pubmed: 31992219 pmcid: 6988257
Morone G, Bragoni M, Iosa M, De Angelis D, Venturiero V, Coiro P, Pratesi L, Paolucci S (2011) Who may benefit from robotic-assisted gait training? A randomized clinical trial in patients with subacute stroke. Neurorehabil Neural Repair 25(7):636–644
doi: 10.1177/1545968311401034 pubmed: 21444654
Mortenson WB, Pysklywec A, Chau L, Prescott M, Townson A (2022) Therapists’ experience of training and implementing an exoskeleton in a rehabilitation centre. Disabil Rehabil 44(7):1060–1066
doi: 10.1080/09638288.2020.1789765 pubmed: 32649239
Nydahl P, Sricharoenchai T, Chandra S, Kundt FS, Huang M, Fischill M, Needham DM (2017) Safety of patient mobilization and rehabilitation in the intensive care unit. Systematic review with meta-analysis. Ann Am Thorac Soc 14(5):766–777
doi: 10.1513/AnnalsATS.201611-843SR pubmed: 28231030
Park G-M, Cho S-H, Hong J-T, Kim D-H, Shin J-C (2023) Effects and safety of wearable exoskeleton for robot-assisted gait training: a retrospective preliminary study. J Pers Med 13(4):676
doi: 10.3390/jpm13040676 pubmed: 37109062 pmcid: 10144215
Ueba T, Hamada O, Ogata T, Inoue T, Shiota E, Sankai Y (2013) Feasibility and safety of acute phase rehabilitation after stroke using the hybrid assistive limb robot suit. Neurol Med Chir 53(5):287–290
doi: 10.2176/nmc.53.287
Winkelman C, Peereboom K (2010) Staff-perceived barriers and facilitators. Crit Care Nurse 30(2):S13–S16. https://doi.org/10.4037/ccn2010393
Winstein CJ, Stein J, Arena R et al (2016) Guidelines for adult stroke rehabilitation and recovery. Stroke 47(6):e98–e169
doi: 10.1161/STR.0000000000000098 pubmed: 27145936

Auteurs

Audrey El Kaim (A)

Neurosurgery Department, Pitié Salpêtrière Hospital, Paris, France.
Institute of Myology, Pitié Salpêtrière Hospital, Paris, France.

Manon Serra (M)

Brain Machine Interface Clinical Research Group, Sorbonne University, Paris, France.
Physical and Rehabilitation Medicine Unit, Pitié Salpêtrière Hospital, Paris, France.
Department of Anesthesia, Critical Care and Perioperative Care, Pitié Salpêtrière Hospital, Paris, France.

Henri De Noray (H)

Neurosurgery Department, Pitié Salpêtrière Hospital, Paris, France.
Department of Anesthesia, Critical Care and Perioperative Care, Pitié Salpêtrière Hospital, Paris, France.

Audrey Lallemant (A)

Neurosurgery Department, Pitié Salpêtrière Hospital, Paris, France.
Department of Anesthesia, Critical Care and Perioperative Care, Pitié Salpêtrière Hospital, Paris, France.

Corentin Gobatto (C)

Neurosurgery Department, Pitié Salpêtrière Hospital, Paris, France.
Department of Anesthesia, Critical Care and Perioperative Care, Pitié Salpêtrière Hospital, Paris, France.

Vincent Degos (V)

Department of Anesthesia, Critical Care and Perioperative Care, Pitié Salpêtrière Hospital, Paris, France.
Sorbonne Université, Paris, France.
Université de Paris, NeuroDiderot, Inserm, 75019, Paris, France.
PremUP, 75006, Paris, France.

Alexandre Carpentier (A)

Neurosurgery Department, Pitié Salpêtrière Hospital, Paris, France.
Brain Machine Interface Clinical Research Group, Sorbonne University, Paris, France.
Sorbonne Université, Paris, France.

Maximilien Riche (M)

Neurosurgery Department, Pitié Salpêtrière Hospital, Paris, France.
Brain Machine Interface Clinical Research Group, Sorbonne University, Paris, France.
Sorbonne Université, Paris, France.

Caroline Apra (C)

Neurosurgery Department, Pitié Salpêtrière Hospital, Paris, France. caroline.apra@neurochirurgie.fr.
Neurosurgery Department, Henri Mondor Hospital, Créteil, France. caroline.apra@neurochirurgie.fr.
Université Paris Est Créteil Val de Marne, Créteil, France. caroline.apra@neurochirurgie.fr.
Mondor Institute of Biomedical Research, INSERM U955, Créteil, France. caroline.apra@neurochirurgie.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH